Respiratory Today—December 5, 2025
This week’s respiratory update highlights major developments across RSV…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
Neuroscience Weekly News - September 10th 2025
🧠 This Week in Neuroscience: PTSD Treatment, MS Stem Cell Therapy and More…
Immunology Weekly News - August 27th 2025
🔬 This week in Immunology Updates: A pivotal biosimilar launch, regulatory…
Endocrinology Weekly Update - July 8th 2025
🧬 Endocrinology Update: Acromegaly Heart Breakthrough, AI in Diabetes, New…
Immunology Weekly News - May 7th 2025
🧠 This Week in Immunology: FDA Approvals, Gene Therapy Breakthroughs &…
Immunology Weekly News - April 23rd 2025
🧬 Weekly Immunology Breakthroughs: Big Moves in Autoimmune, AI, and Allergy…
Immunology Weekly News - April 16th 2025
🧬 Weekly Immunology Breakthroughs: Adolescent Psoriasis, PsA Joint Protection,…
How Education can serve as a catalyst for wider Biosimilar Adoption.
Even two decades after their introduction, the global adoption rate of…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
How we helped a Top-20 Pharma competitively position its asset in the oncology biosimilars’ space.
The challenge: Strategically positioning an asset in the oncology biosimilars…
How we collaborated with a medium-sized pharma in the oncology biosimilars space so that they could make the most out of the ESMO conference.
The Challenge: Taking away key industry insights during a large international…